## **Core Concept**
Naloxone is an opioid antagonist used to counteract life-threatening depression of the central nervous system and respiratory system, allowing an overdose victim to breathe normally again. It works by competitively binding to opioid receptors, displacing opioids. In the context of neonatal resuscitation, the concern is about the maternal use of opioids and its impact on the newborn.

## **Why the Correct Answer is Right**
The correct answer, . (Buprenorphine), is a partial opioid agonist. Naloxone can precipitate withdrawal in opioid-dependent individuals. However, buprenorphine, being a partial agonist, poses a unique challenge. Naloxone can cause severe withdrawal symptoms in a neonate exposed to buprenorphine in utero because it displaces buprenorphine from opioid receptors, leading to severe opioid withdrawal in the newborn.

## **Why Each Wrong Option is Incorrect**
- **Option A:** (Morphine) - While morphine is an opioid and naloxone is used to reverse opioid effects, morphine use does not specifically contraindicate naloxone use in neonates; rather, naloxone is indicated to reverse opioid-induced respiratory depression.
- **Option C:** (Cocaine) - Cocaine is not an opioid; it's a stimulant. Naloxone does not have a role in reversing cocaine effects, but cocaine use by the mother does not contraindicate naloxone use in the neonate for opioid reversal.
- **Option D:** (Amphetamine) - Like cocaine, amphetamines are stimulants, not opioids. Naloxone is not indicated for amphetamine overdose, but amphetamine use does not contraindicate naloxone for neonatal opioid reversal.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that naloxone administration in the setting of neonatal resuscitation should be considered when there is evidence of opioid exposure. However, caution is advised with maternal buprenorphine use due to the risk of precipitating withdrawal in the neonate.

## **Correct Answer:** . Buprenorphine